soul trial oral semaglutide cardiovascular outcomes 2024 results mace Effect of versus placebo on cardiorenal by prior disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6 - Zhou Oral Semaglutide and Cardiovascular Outcomes

It means you will lose weight by shedding extra fats without affecting muscle mass and water content in the body

Semaglutide GLP-1 is a glucagon-like peptide-1 (GLP-1 receptor agonist) that belongs to a class of drugs called incretin mimetics

it is a regulator

Portfolio assessment: Identifying where volume pressure is structural and where premium repositioning is viable Consumer and market research: Combining proprietary survey data, transaction data and industry expertise to map shifting demand Growth strategy: Build a view of categories, formats and consumer segments offering the most definitive path to growth Business forecast support: Developing investment and growth plans aligned to the evolution of consumers and core categories Those that move now, through honest portfolio reviews, nutrition-aligned innovation, and communications that speak to the health-conscious consumer, will be far better positioned for a market that has already begun to change around them

All diuretic doses were converted to furosemide equivalents

Carr KA, Epstein LH